Y-mAbs Therapeutics, Inc. Operating Lease Right-of-Use Assets
Y-mAbs Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $3.11 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-08-08
- 2025-06-30: Operating Lease, Right-of-Use Asset $3.11M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $601.00K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $817.00K.
- 2024-09-30: Operating Lease, Right-of-Use Asset $1.07M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-06-30 | $3.11M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $601.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $817.00K 10-Q · filed 2025-08-08 |
| 2024-09-30 | $1.07M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.27M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.18M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.41M 10-K · filed 2025-03-04 |
| 2023-09-30 | $1.59M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.37M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.74M 10-K · filed 2024-02-29 |
| 2022-09-30 | $2.17M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.38M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $3.15M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.84M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.40M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.98M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.57M 10-K · filed 2022-03-01 |
| 2020-09-30 | $5.12M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.76M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.86M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.99M 10-K · filed 2021-03-01 |
| 2019-09-30 | $2.09M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $2.22M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.32M 10-Q · filed 2019-05-10 |